Patchett S, Beattie S, Leen E, Keane C, O'Morain C
Meath Hospital, Dublin, Republic of Ireland.
BMJ. 1991 Nov 16;303(6812):1238-40. doi: 10.1136/bmj.303.6812.1238.
To examine the effect of eradication of Helicobacter pylori on symptoms of non-ulcer dyspepsia.
Four week prospective study.
One hospital outpatient and endoscopy department.
90 adults with persistent symptoms typical of non-ulcer dyspepsia but no clinical or endoscopic evidence of other peptic, biliary, pancreatic, or malignant disease; all had histological and microbiological evidence of infection with H pylori. 83 patients completed the treatment regimen.
Colloidal bismuth subcitrate 120 mg four times a day for four weeks (27 patients); metronidazole 400 mg and amoxycillin 500 mg each three times a day for one week (27); and bismuth subcitrate 120 mg four times a day for four weeks, metronidazole 400 mg three times a day for one week, plus amoxycillin 500 mg three times a day for the first week (29).
Change in symptom scores determined with questionnaire; histological evidence of gastritis and microbiological evidence of presence of H pylori in biopsy specimens.
Overall, H pylori was eradicated in 41 (49%) patients. Although gastritis scores improved significantly in only patients in whom H pylori had been eradicated (from 1.56 to 0.61, p less than 0.01 v from 1.83 to 1.07, p = 0.52) mean symptom scores after treatment were similar in patients in whom H pylori had or had not been eradicated (3.0 v 2.3, NS). Similarly the mean symptom score improved whether or not gastritis improved (2.8 v 3.1 respectively, p = 0.72). The observations were similar for treatment groups analysed individually.
Antral infection with the organism does not seem to have an important aetiological role in non-ulcer dyspepsia short term.
研究根除幽门螺杆菌对非溃疡性消化不良症状的影响。
为期四周的前瞻性研究。
一家医院的门诊及内镜科。
90名有持续典型非溃疡性消化不良症状但无其他消化性、胆、胰或恶性疾病临床及内镜证据的成年人;所有患者均有幽门螺杆菌感染的组织学及微生物学证据。83名患者完成了治疗方案。
枸橼酸铋钾120毫克,每日4次,共4周(27例患者);甲硝唑400毫克及阿莫西林500毫克,每日各3次,共1周(27例);枸橼酸铋钾120毫克,每日4次,共4周,甲硝唑400毫克,每日3次,共1周,加阿莫西林500毫克,第1周每日3次(29例)。
通过问卷确定症状评分的变化;活检标本中胃炎的组织学证据及幽门螺杆菌存在的微生物学证据。
总体而言,41例(49%)患者的幽门螺杆菌被根除。虽然仅在幽门螺杆菌被根除的患者中胃炎评分显著改善(从1.56降至0.61,p<0.01;与之相比,未根除者从1.83降至1.07,p = 0.52),但幽门螺杆菌被根除和未被根除的患者治疗后的平均症状评分相似(分别为3.0和2.3,无显著差异)。同样,无论胃炎是否改善,平均症状评分均有改善(分别为2.8和3.1,p = 0.72)。对各治疗组单独分析时观察结果相似。
短期内,该菌在胃窦部的感染似乎在非溃疡性消化不良中并无重要的病因学作用。